Anthem Inc (A58) - Net Assets

Latest as of December 2025: €44.03 Billion EUR

Based on the latest financial reports, Anthem Inc (A58) has net assets worth €44.03 Billion EUR as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€121.49 Billion) and total liabilities (€77.47 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €44.03 Billion
% of Total Assets 36.24%
Annual Growth Rate 6.69%
5-Year Change 21.86%
10-Year Change 75.4%
Growth Volatility 2.77

Anthem Inc - Net Assets Trend (2015–2025)

This chart illustrates how Anthem Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Anthem Inc (2015–2025)

The table below shows the annual net assets of Anthem Inc from 2015 to 2025.

Year Net Assets Change
2025-12-31 €44.03 Billion +6.28%
2024-12-31 €41.43 Billion +5.13%
2023-12-31 €39.41 Billion +8.27%
2022-12-31 €36.39 Billion +0.74%
2021-12-31 €36.13 Billion +8.82%
2020-12-31 €33.20 Billion +4.64%
2019-12-31 €31.73 Billion +11.17%
2018-12-31 €28.54 Billion +7.69%
2017-12-31 €26.50 Billion +5.59%
2016-12-31 €25.10 Billion +8.92%
2015-12-31 €23.04 Billion --

Equity Component Analysis

This analysis shows how different components contribute to Anthem Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 139.5% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings €35.39 Billion 80.65%
Other Components €8.49 Billion 19.35%
Total Equity €43.88 Billion 100.00%

Anthem Inc Competitors by Market Cap

The table below lists competitors of Anthem Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Anthem Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 41,315,000,000 to 43,882,000,000, a change of 2,567,000,000 (6.2%).
  • Net income of 5,662,000,000 contributed positively to equity growth.
  • Dividend payments of 1,529,000,000 reduced retained earnings.
  • Share repurchases of 2,605,000,000 reduced equity.
  • Other factors increased equity by 1,039,000,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €5.66 Billion +12.9%
Dividends Paid €1.53 Billion -3.48%
Share Repurchases €2.60 Billion -5.94%
Other Changes €1.04 Billion +2.37%
Total Change €- 6.21%

Book Value vs Market Value Analysis

This analysis compares Anthem Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.36x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 2.61x to 1.36x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 €103.49 €270.30 x
2018-12-31 €110.88 €270.30 x
2019-12-31 €125.45 €270.30 x
2020-12-31 €135.28 €270.30 x
2021-12-31 €148.49 €270.30 x
2022-12-31 €152.58 €270.30 x
2023-12-31 €168.64 €270.30 x
2024-12-31 €181.62 €270.30 x
2025-12-31 €198.81 €270.30 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Anthem Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 12.90%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 2.84%
  • • Asset Turnover: 1.64x
  • • Equity Multiplier: 2.77x
  • Recent ROE (12.90%) is below the historical average (13.97%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 11.11% 3.23% 1.28x 2.68x €255.59 Million
2016 9.84% 2.91% 1.30x 2.59x €-40.24 Million
2017 14.50% 4.27% 1.28x 2.66x €1.19 Billion
2018 13.14% 4.07% 1.29x 2.51x €895.90 Million
2019 15.15% 4.61% 1.35x 2.44x €1.63 Billion
2020 13.77% 3.75% 1.41x 2.61x €1.25 Billion
2021 16.93% 4.40% 1.42x 2.70x €2.50 Billion
2022 16.59% 3.85% 1.52x 2.83x €2.39 Billion
2023 15.23% 3.49% 1.57x 2.77x €2.06 Billion
2024 14.47% 3.38% 1.51x 2.83x €1.85 Billion
2025 12.90% 2.84% 1.64x 2.77x €1.27 Billion

Industry Comparison

This section compares Anthem Inc's net assets metrics with peer companies in the Healthcare Plans industry.

Industry Context

  • Industry: Healthcare Plans
  • Average net assets among peers: $308,704,000
  • Average return on equity (ROE) among peers: -27.71%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Anthem Inc (A58) €44.03 Billion 11.11% 1.76x $60.83 Billion
CLOVER HEALTH INV. CL.A (7QD) $308.70 Million -27.71% 0.75x $807.40 Million

About Anthem Inc

F:A58 Germany Healthcare Plans
Market Cap
$69.42 Billion
€59.38 Billion EUR
Market Cap Rank
#386 Global
#17 in Germany
Share Price
€270.30
Change (1 day)
-0.66%
52-Week Range
€235.80 - €387.30
All Time High
€536.33
About

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad… Read more